Brown, Lisle/Cummings’s BlackRock Health Sciences Trust II BMEZ Stock Holding History
Bought
Maintained
Sold
Other funds holding BMEZ
RCM
SCM
1CP
Brown, Lisle/Cummings's BMEZ Position: Q1 2026 in Review
Brown, Lisle/Cummings increased its BlackRock Health Sciences Trust II (BMEZ) stake by 4.2% in Q1 2026, buying an estimated $32K and bringing the position to 52,918 shares worth $760K. The position accounts for 0.19% of the portfolio, ranked #117.
Brown, Lisle/Cummings first reported a position in BMEZ in Q4 2021 and has held it in 18 quarters since. The position peaked at $764K in Q4 2025. 88 funds tracked by Wall St. Rank hold BMEZ as of Q1 2026.
- Brown, Lisle/Cummings held 52,918 shares of BlackRock Health Sciences Trust II worth $760K as of Q1 2026.
- Brown, Lisle/Cummings bought 2,154 BlackRock Health Sciences Trust II shares in Q1 2026, an estimated $32K.
- BlackRock Health Sciences Trust II made up 0.19% of Brown, Lisle/Cummings's portfolio in Q1 2026, its #117 holding.
- Brown, Lisle/Cummings first reported a position in BlackRock Health Sciences Trust II in Q4 2021 and has held it in 18 quarters since.
- Brown, Lisle/Cummings's BlackRock Health Sciences Trust II position peaked at $764K in Q4 2025.
- 88 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q1 2026.
Based on Brown, Lisle/Cummings's 13F filing for Q1 2026, filed 20 Apr 2026.